Marrone Salvatore, Scalia Gianluca, Atallah Oday, Scibilia Giuseppe, Palmisciano Paolo, Chaurasia Bipin, Maugeri Rosario, Iacopino Domenico Gerardo, Graziano Francesca, Mastronardi Luciano, Tomasi Ottavio S, Naimo Jessica, Ferini Gianluca, Scollo Paolo, Umana Giuseppe Emmanuele
Department of Neurosurgery, Sant'Elia Hospital, Caltanissetta, Italy.
Neurosurgery Unit, Highly Specialized Hospital of National Importance "Garibaldi", Catania, Italy.
Neurosurg Rev. 2025 Mar 28;48(1):335. doi: 10.1007/s10143-025-03484-3.
γ-Glutamyl Hydroxymethyl Rhodamine Green (γ-GHRG) fluorescence is a novel fluorescent agent used to enhance tissue visualization during surgical resections, especially in oncological procedures. This systematic review aims to evaluate the efficacy of γ-GHRG fluorescence in improving tumor margin detection, reducing recurrence rates, and enhancing surgical precision. A comprehensive search was conducted across PubMed, Embase, and Cochrane databases up to February 2024, following PRISMA guidelines. A total of 23 studies investigating the use of γ-GHRG fluorescence in surgical resection were included. Data on tumor visualization, surgical margin detection, and postoperative outcomes were analyzed. The included studies demonstrated that γ-GHRG fluorescence significantly improved tumor visualization in a variety of cancers, including ovarian cancer (26.1%), breast cancer (8.7%), lung cancer (8.7%), colorectal cancer (8.7%), kidney cancer (8.7%), head and neck cancer (8.7%), esophageal and gastric cancer (8.7%), prostate cancer (8.7%), brain tumors (gliomas) (4.3%), and liver cancer (4.3%). The probe's high specificity for γ-glutamyl transpeptidase (GGT), which is overexpressed in cancer cells, enabled real-time visualization of tumor margins, allowing for more precise resections. Studies also reported shorter surgical times and lower recurrence rates, particularly in high-grade tumors such as gliomas (4.3%). Although the results are promising, issues related to false positives, tissue specificity, and long-term safety were noted. γ-GHRG fluorescence shows significant potential in enhancing surgical outcomes by providing real-time guidance during tumor resections. Its high specificity for GGT and rapid fluorescence activation make it a valuable tool in cancer surgery. However, further clinical studies are required to address challenges related to sensitivity, specificity, and long-term safety, as well as to explore its application across different cancer types and surgical settings.
γ-谷氨酰羟甲基罗丹明绿(γ-GHRG)荧光是一种新型荧光剂,用于在手术切除过程中增强组织可视化,尤其是在肿瘤手术中。本系统评价旨在评估γ-GHRG荧光在改善肿瘤切缘检测、降低复发率和提高手术精度方面的疗效。按照PRISMA指南,截至2024年2月,对PubMed、Embase和Cochrane数据库进行了全面检索。共纳入23项研究γ-GHRG荧光在手术切除中应用的研究。分析了有关肿瘤可视化、手术切缘检测和术后结果的数据。纳入的研究表明,γ-GHRG荧光在多种癌症中显著改善了肿瘤可视化,包括卵巢癌(26.1%)、乳腺癌(8.7%)、肺癌(8.7%)、结直肠癌(8.7%)、肾癌(8.7%)、头颈癌(8.7%)、食管癌和胃癌(8.7%)、前列腺癌(8.7%)、脑肿瘤(胶质瘤)(4.3%)和肝癌(4.3%)。该探针对癌细胞中过表达的γ-谷氨酰转肽酶(GGT)具有高特异性,能够实时可视化肿瘤切缘,从而实现更精确的切除。研究还报告了手术时间缩短和复发率降低,尤其是在高级别肿瘤如胶质瘤(4.3%)中。尽管结果很有前景,但也注意到了与假阳性、组织特异性和长期安全性相关的问题。γ-GHRG荧光通过在肿瘤切除过程中提供实时指导,在改善手术结果方面显示出巨大潜力。其对GGT的高特异性和快速荧光激活使其成为癌症手术中的一种有价值的工具。然而,需要进一步的临床研究来解决与敏感性、特异性和长期安全性相关的挑战,并探索其在不同癌症类型和手术环境中的应用。